Cambridge Investment Research Advisors
NARI

Cambridge Investment Research Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,799
Closed -$1.66M – 3314
2023
Q1 		$1.66M Buy
+26,799
New +$1.61M 0.01% 1235

Other funds holding NARI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Cambridge Investment Research Advisors's NARI Position: Q2 2023 in Review

Cambridge Investment Research Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2023, closing a stake of 26,799 shares — an estimated $1.66M sold.

Cambridge Investment Research Advisors first reported a position in NARI in Q1 2023 and held it in 1 quarter. The position peaked at $1.66M in Q1 2023. 250 funds tracked by Wall St. Rank hold NARI as of Q2 2023.

  • Cambridge Investment Research Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 26,799 Inari Medical, Inc. Common Stock shares in Q2 2023, an estimated $1.66M.
  • Cambridge Investment Research Advisors first reported a position in Inari Medical, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Inari Medical, Inc. Common Stock position peaked at $1.66M in Q1 2023.
  • 250 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.